COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions.

Back, David; Marzolini, Catia; Hodge, Catherine; Marra, Fiona; Boyle, Alison; Gibbons, Sara; Burger, David; Khoo, Saye

Back, David; Marzolini, Catia; Hodge, Catherine; Marra, Fiona; Boyle, Alison; Gibbons, Sara; Burger, David; Khoo, Saye.

Afiliação

Back D; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Marzolini C; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Hodge C; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel, Basel, Switzerland.
Marra F; University of Basel, Basel, Switzerland.
Boyle A; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Gibbons S; Department of Pharmacy, NHS Greater Glasgow and Clyde, Glasgow, UK.
Burger D; Department of Pharmacy, NHS Greater Glasgow and Clyde, Glasgow, UK.
Khoo S; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

Br J Clin Pharmacol ; 87(1): 212-213, 2021 01.

Article em En | MEDLINE | ID: mdl-32384171

Assuntos

Antivirais; Tratamento Farmacológico da COVID-19; Preparações Farmacêuticas; Comorbidade; Interações Medicamentosas; Reposicionamento de Medicamentos; Humanos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Preparações Farmacêuticas / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google